Clinical Trial Update: Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating ilaprazole for gastroesophageal reflux disease in Chinese patients has completed. The snippet does not include trial results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Ilaprazole (ilaprazole)

Snippet

Sponsor: Livzon Pharmaceutical Group Inc. | Conditions: Gastroesophageal Reflux Disease | Phase 3 | Status: COMPLETED